Form S-3 Lexaria Bioscience Corp.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up over 1% as Saudi Arabian refinery attack reignites supply risk concerns
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- UBS now expects two additional Fed rate hikes by the middle of 2027
- S&P Global explores potential separation of Capital IQ business
- Wall Street ends higher on revived AI momentum
- Nebius Group shares jump after France data center funding
- Seagate Technology (STX) Tops Q1 EPS by 29c, Offers Guidance
- GE Vernova Inc. (GEV) Tops Q3 EPS by 81c, Beats on Revenue; Offers FY26 Revenue Guidance
Lexaria Bioscience (LEXX) Files for 4.55M Share Offering
November 26, 2024 4:47 PM ESTLexaria Bioscience (NASDAQ: LEXX) has filed the following:
This prospectus relates to the resale from time to time by the selling stockholder identified herein of up to 4,551,019 shares of common stock, $0.001 par value (Common Stock), underlying those certain private placement warrants (the Common... More



